Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1137/week)
Manufacturing
(503/week)
Technology
(1099/week)
Energy
(372/week)
Other Manufacturing
(333/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
IDEAYA Biosciences, Inc.
May 30, 2025
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 06, 2025
IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
Apr 01, 2025
IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events
Mar 31, 2025
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma
Mar 28, 2025
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mar 03, 2025
IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets
Feb 10, 2025
IDEAYA Biosciences Announces Appointment of Healthcare Investment Banking Veteran Joshua Bleharski as Chief Financial Officer
Jan 27, 2025
IDEAYA Biosciences to Participate in Upcoming February 2025 Investor Relations Events
Jan 12, 2025
IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance
Dec 29, 2024
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
Dec 27, 2024
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Dec 17, 2024
IDEAYA Announces IDMC Recommendation of Move-Forward Dose in Part 2a of Registration-Enabling Trial of Darovasertib and Crizotinib Combination in 1L HLA-A2-Negative Metastatic Uveal Melanoma
Dec 16, 2024
IDEAYA Announces Development Candidate Nomination of IDE251, a Potential First-in-Class KAT6/7 Dual Inhibitor Targeting 8p11 Amplification Tumors in Breast and Lung Cancers
Dec 11, 2024
IDEAYA Announces Agenda for Investor R&D Day Webcast on December 16, 2024
Dec 10, 2024
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
Dec 09, 2024
IDEAYA Biosciences Announces Development Candidate Nomination of IDE892, a Potential Best-in-Class MTA-cooperative PRMT5 Inhibitor
Dec 06, 2024
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Dec 02, 2024
IDEAYA Biosciences Announces Participation in Upcoming December 2024 Investor Relations Events
Nov 29, 2024
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nov 12, 2024
IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R&D Day
Page 1
››
Latest News
Jun 3, 2025
Oshkosh Corporation Renames Defense Segment to Transport Segment and Appoints Steve Nordlund as President
Jun 3, 2025
Constellation, Meta Sign 20-Year Deal for Clean, Reliable Nuclear Energy in Illinois
Jun 3, 2025
Polestar Sets Date for AGM and Announces Board Changes
Jun 3, 2025
Ninety-Five Percent of Manufacturers Are Investing in AI to Navigate Uncertainty and Accelerate Smart...
Jun 3, 2025
Davidson Instruments, Inc. sues Parker-Hannifin Corporation, alleging antitrust violations, theft of trade...
Jun 3, 2025
Venture Global Launches Site Work at CP2 LNG Following Federal Approval
Jun 3, 2025
Marco Adds Product Depth with Acquisition of Colonial Seal Company
Jun 3, 2025
X-energy Receives ISO-9001 Quality Management System Certification
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events